Free shipping on all orders over $ 500

TH1834

Cat. No. M9919
TH1834 Structure
Synonym:

TH-1834

Size Price Availability
10mg USD 360  USD360 Out of stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

TH1834 is a specific Tip60 (KAT5) histone acetyltransferase (HAT) inhibitor. TH1834 significantly inhibits Tip60 activity in vitro and treating cells with TH1834 results in apoptosis and increased unrepaired DNA damage in breast cancer.

Chemical Information
Molecular Weight 568.71
Formula C33H40N6O3
CAS Number 2108830-08-4
Solubility (25°C) DMSO 5 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Chunxia Gao, et al. Sci Rep. Rational design and validation of a Tip60 histone acetyltransferase inhibitor

Related Histone Acetyltransferase Products
AU-18069

AU-18069 is a CBP/p300 HAT inhibitor that can be used in studies related to hematological and solid tumors.

KAT modulator-1

KAT modulator-1 is a KAT modulator.

KAT6-IN-1

KAT6-IN-1 is a potent KAT6 inhibitor.

MC4171

MC4171 is a selective KAT8 inhibitor (IC50=8.1 µM).

MOZ-IN-3

MOZ-IN-3 is a KAT6A (MOZ) acetyltransferase inhibitor (IC50: 30 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: TH1834, TH-1834 supplier, Histone Acetyltransferase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.